Michael Hay. Show Affiliations »
Abstract
Mesh: See more » Anti-Obesity Agents/adverse effectsAnti-Obesity Agents/therapeutic useBenzazepines/adverse effectsBenzazepines/therapeutic useDrug ApprovalDrug CombinationsDrug Evaluation, PreclinicalFructose/analogs & derivativesFructose/therapeutic useHumansPhentermine/therapeutic useTopiramateUnited StatesUnited States Food and Drug Administration
Substances: See more » Anti-Obesity AgentsBenzazepinesDrug CombinationsTopiramateFructoselorcaserinPhentermine
Year: 2010 PMID: 20592737 DOI: 10.1038/nrd3225
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694